BioCryst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $4.03-$8.88 |
Market Cap | $1.5B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $412.5M |
Revenue Growth (YoY) | 35% |
Gross Profit (12 Mos) | $10.9M |
Diluted EPS | -$0.61 |
News
See moreYahoo Finance • 5 months ago
BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
Yahoo Finance • 8 months ago
12 Best Depressed Stocks To Buy in 2024
Yahoo Finance • 12 months ago
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina
Yahoo Finance • last year
BioCryst to Present at Upcoming Investor Conferences
About
CEO | Mr. Jon P. Stonehouse |
CFO | Mr. Anthony J. Doyle |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 536 |
